From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with the growing internal contradictions of the commercialized life sciences. Melinda Cooper is a research fellow with the Centre for Biomedicine and Society, Kings College London.
Read More
From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with the growing internal contradictions of the commercialized life sciences. Melinda Cooper is a research fellow with the Centre for Biomedicine and Society, Kings College London.
Read Less